These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 25531796)

  • 61. Fecal calprotectin: towards a standardized use for inflammatory bowel disease management in routine practice.
    Louis E
    J Crohns Colitis; 2015 Jan; 9(1):1-3. PubMed ID: 25536671
    [No Abstract]   [Full Text] [Related]  

  • 62. Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort.
    Isene R; Bernklev T; Høie O; Munkholm P; Tsianos E; Stockbrügger R; Odes S; Palm Ø; Småstuen M; Moum B;
    Scand J Gastroenterol; 2015 Mar; 50(3):300-5. PubMed ID: 25535653
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of Growth in Children with Inflammatory Bowel Disease.
    Altaş U; Ertem D
    Children (Basel); 2024 Aug; 11(9):. PubMed ID: 39334571
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Functional hypogonadism in adolescence: an overlooked cause of secondary hypogonadism.
    Esquivel-Zuniga R; Rogol AD
    Endocr Connect; 2023 Nov; 12(11):. PubMed ID: 37615381
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Running Behind "POPO"-Impact of Predictors of Poor Outcome for Treatment Stratification in Pediatric Crohn's Disease.
    de Laffolie J; Zimmer KP; Sohrabi K; Hauer AC
    Front Med (Lausanne); 2021; 8():644003. PubMed ID: 34513855
    [No Abstract]   [Full Text] [Related]  

  • 66. Growth, puberty, and bone health in children and adolescents with inflammatory bowel disease.
    Jin HY; Lim JS; Lee Y; Choi Y; Oh SH; Kim KM; Yoo HW; Choi JH
    BMC Pediatr; 2021 Jan; 21(1):35. PubMed ID: 33446154
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Changes in MMP-2, MMP-9, inflammation, blood coagulation and intestinal mucosal permeability in patients with active ulcerative colitis.
    Bai X; Bai G; Tang L; Liu L; Li Y; Jiang W
    Exp Ther Med; 2020 Jul; 20(1):269-274. PubMed ID: 32536995
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Body image dissatisfaction in patients with inflammatory bowel disease: a systematic review.
    Beese SE; Harris IM; Dretzke J; Moore D
    BMJ Open Gastroenterol; 2019; 6(1):e000255. PubMed ID: 30899537
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Thiopurines are negatively associated with anthropometric parameters in pediatric Crohn's disease.
    Gupta N; Lustig RH; Chao C; Vittinghoff E; Andrews H; Leu CS
    World J Gastroenterol; 2018 May; 24(18):2036-2046. PubMed ID: 29760546
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Growth patterns in early juvenile idiopathic arthritis: Results from the Childhood Arthritis Prospective Study (CAPS).
    McErlane F; Carrasco R; Kearsley-Fleet L; Baildam EM; Wedderburn LR; Foster HE; Ioannou Y; Chieng SEA; Davidson JE; Thomson W; Hyrich KL
    Semin Arthritis Rheum; 2018 Aug; 48(1):53-60. PubMed ID: 29217290
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Growth Hormone Resistance-Special Focus on Inflammatory Bowel Disease.
    Soendergaard C; Young JA; Kopchick JJ
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28486400
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Assessing the feasibility of injectable growth-promoting therapy in Crohn's disease.
    Altowati MA; Jones AP; Hickey H; Williamson PR; Barakat FM; Plaatjies NC; Hardwick B; Russell RK; Jaki T; Ahmed SF; Sanderson IR
    Pilot Feasibility Stud; 2016; 2():71. PubMed ID: 27965886
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Changing Face of Very Early-Onset Inflammatory Bowel Disease.
    Mezoff EA; Dykes DM
    J Pediatr; 2015 Sep; 167(3):508-9. PubMed ID: 26163080
    [No Abstract]   [Full Text] [Related]  

  • 74. Effect of testosterone therapy for delayed growth and puberty in boys with inflammatory bowel disease.
    Mason A; Wong SC; McGrogan P; Ahmed SF
    Horm Res Paediatr; 2011; 75(1):8-13. PubMed ID: 20664179
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The growth hormone insulin-like growth factor 1 axis in children and adolescents with inflammatory bowel disease and growth retardation.
    Wong SC; Smyth A; McNeill E; Galloway PJ; Hassan K; McGrogan P; Ahmed SF
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):220-8. PubMed ID: 20184596
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Growth retardation in early-onset inflammatory bowel disease: should we monitor and treat these patients differently?
    Griffiths AM
    Dig Dis; 2009; 27(3):404-11. PubMed ID: 19786772
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A prospective longitudinal study of growth and pubertal progress in adolescents with inflammatory bowel disease.
    Mason A; Malik S; McMillan M; McNeilly JD; Bishop J; McGrogan P; Russell RK; Ahmed SF
    Horm Res Paediatr; 2015; 83(1):45-54. PubMed ID: 25531796
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impact of inflammatory bowel disease on pubertal growth.
    Mason A; Malik S; Russell RK; Bishop J; McGrogan P; Ahmed SF
    Horm Res Paediatr; 2011; 76(5):293-9. PubMed ID: 22024935
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.